1. Ki67 targeted strategies for cancer therapy
   C. Yang et al, 2018, Clinical and Translational Oncology CrossRef
2. Delivery systems for enhancing oncolytic adenoviruses efficacy
   Yu-Cheng Zhou et al, 2020, International Journal of Pharmaceutics CrossRef
3. Fighting Fire With Fire: Oncolytic Virotherapy for Thoracic Malignancies
   Chigozirim N. Ekeke et al, 2021, Annals of Surgical Oncology CrossRef
4. Advances in cell-based delivery of oncolytic viruses as therapy for lung cancer
   Giti Esmail Nia et al, 2024, Molecular Therapy: Oncology CrossRef
5. The Association of microRNA-34a With High Incidence and Metastasis of Lung Cancer in Gejiu and Xuanwei Yunnan
   Yan Chen et al, 2021, Frontiers in Oncology CrossRef
6. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101
   Chao-Bin He et al, 2017, PLOS ONE CrossRef
7. Oncolytic virus immunotherapies in ovarian cancer: moving beyond adenoviruses
   Joseph Hoare et al, 2018, Porto Biomedical Journal CrossRef
8. Oncolytic viruses in lung cancer treatment: a review article
   Hanie Sakhi et al, 2024, Immunotherapy CrossRef
9. E4orf1: The triple agent of adenovirus – Unraveling its roles in oncogenesis, infectious obesity and immune responses in virus replication and vector therapy
   Lilian Göttig et al, 2024, Tumour Virus Research CrossRef
10. shRNA-armed conditionally replicative adenoviruses: a promising approach for cancer therapy
    Jie Zhang et al, 2016, Oncotarget CrossRef
11. Targeting Cancer Stem Cells: New Perspectives for a Cure to Cancer
    Beatrice Aramini et al, 2022, Handbook of Stem Cell Therapy CrossRef
12. Oncolytic ImmunoViroTherapy: A long history of crosstalk between viruses and immune system for cancer treatment
    S. Feola et al, 2022, Pharmacology & Therapeutics CrossRef
13. Targeting Cancer Stem Cells: New Perspectives for a Cure to Cancer
    Beatrice Aramini et al, 2022, Handbook of Stem Cell Therapy CrossRef
14. A Tumor-Targeted Replicating Oncolytic Adenovirus Ad-TD-nsIL12 as a Promising Therapeutic Agent for Human Esophageal Squamous Cell Carcinoma
    Zifang Zhang et al, 2020, Cells CrossRef
15. Strategies for enhancing intratumoral spread of oncolytic adenoviruses
    Nasser Hashemi Goradel et al, 2020, Pharmacology & Therapeutics CrossRef
16. MicroRNA Modification of Coxsackievirus B3 Decreases Its Toxicity, while Retaining Oncolytic Potency against Lung Cancer
    Huitao Liu et al, 2020, Molecular Therapy - Oncolytics CrossRef
17. The oncolytic virus H101 combined with GNAQ siRNA‐mediated knockdown reduces uveal melanoma cell viability
    Yongyun Li et al, 2019, Journal of Cellular Biochemistry CrossRef
18. Intraperitoneal oncolytic virotherapy for patients with malignant ascites: Characterization of clinical efficacy and antitumor immune response
    Yalei Zhang et al, 2022, Molecular Therapy - Oncolytics CrossRef
19. Metabolome-Driven Regulation of Adenovirus-Induced Cell Death
    Anastasia Laevskaya et al, 2021, International Journal of Molecular Sciences CrossRef
20. A Renaissance for Oncolytic Adenoviruses?
    Paola Blanchette et al, 2023, Viruses CrossRef